... studies [...] This scale-up will be performed at the Company's new cGMP-capable manufacturing facilities in Shelton, CT." "Since a nanoviricide drug is not a simple small chemical or an antibody, development of these tests is relatively complex, and ...
via Shelton Newswire http://ift.tt/14xmrDo
via Shelton Newswire http://ift.tt/14xmrDo
No comments:
Post a Comment